17/11/2015 - 22:44
BARCELONA – A new look at aducanumab’s phase I study data has reinforced the developer’s confidence that its newly launched phase III trials are targeting the right group: patients with very early...
Field of Interest: Geriatrics
News Feed: Internal Medicine News - Geriatrics